LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
14.12
-0.01 (-0.07%)
Apr 1, 2025, 10:43 AM EDT - Market open
LENSAR Market Cap
LENSAR has a market cap or net worth of $166.47 million as of April 1, 2025. Its market cap has increased by 329.67% in one year.
Market Cap
166.47M
Enterprise Value
146.63M
1-Year Change
329.67%
Ranking
Category
Stock Price
$14.12
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $166.47M, an increase of 113.40%. That is a compound annual growth rate of 18.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 166.47M | 60.32% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | 77.13M | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |